Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...

Add this topic to your repo To associate your repository with the obb-injector-hack topic, visit your repo's landing page and select "manage topics." Learn more ...